-+ 0.00%
-+ 0.00%
-+ 0.00%

Tango Therapeutics announces annual shareholder meeting

PUBT·04/17/2026 11:13:36
Listen to the news
Tango Therapeutics announces annual shareholder meeting
  • Tango Therapeutics scheduled 2026 annual stockholders meeting to be held virtually on June 4, 2026.
  • Shareholders will vote on election of three Class II directors to serve until 2029.
  • Ballot includes ratification of PricewaterhouseCoopers as independent registered public accounting firm for fiscal year ending Dec. 31, 2026.
  • Advisory vote will be held on compensation of named executive officers.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tango Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-160287), on April 17, 2026, and is solely responsible for the information contained therein.